Annotation Detail for ARAP3

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04144 | Endocytosis |
Pathway ID | Pathway Name |
---|
| Signaling by Rho GTPases |
Pathway ID | Pathway Name |
---|
200098 | Class I PI3K signaling events |
200050 | Regulation of RhoA activity |
Desease ID | Desease Name |
---|
2087 | Bacterial infection |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA | affects cotreatment|decreases expression | 17404688
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA | affects cotreatment|decreases expression | 17404688
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.18 | 11473722 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
6.41 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
5.02 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.17 | 16675129 17261762 12948864 18497071 17289903 19861407 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.17 | 17614352 15562024 16175315 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.35 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.80 | 16924424 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
3.09 | 18566989 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.88 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
5.26 | 17187935 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.45 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.28 | 19148513 11473722 18566989 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
4.27 | 16134523 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
6.10 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.82 | 17088409 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
5.17 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.81 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.26 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.83 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.41 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.69 | 14659978 14716833 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
7.04 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
7.04 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.55 | 19453300 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.66 | 16810080 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.62 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.32 | 16427766 11399458 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.26 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.26 | 17393432 16525653 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.44 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.01 | 16740699 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.98 | 18045962 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
5.17 | 15862959 16503802 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.76 | 19048282 |